BCAX Bicara Therapeutics Inc.
$22.81
Bicara Therapeutics Inc. (BCAX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Insider signal
In line
Selling ran in line with BCAX's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity
0 buyers in the last 30 days
0 buyers in the last 90 days
3 sellers in the last 90 days
Insiders buying
1
1 transaction
Insiders selling
5
73 transactions
Purchases
$4.8M
300,000 shares
Sales
$13.7M
676,536 shares
Net activity
-$8.9M
purchases less sales
How much of that selling was preplanned? 100% planned / 0% discretionary
10b5-1 plan sales
$13.7M
73 transactions · 676,536 shares
Discretionary sales
$0
0 transactions · 0 shares
Largest single sale: $776.4K.
Where they traded
Buy
Sell
Dot area is proportional to transaction value.
Last open-market purchase: February 26, 2026 .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan 2 fills | President, COO & Interim CEO | Sell 10b5-1 | 17,500 | $22.90 | $400.7K | 185,083 −8.6% of holding | |
| Cohlhepp Ryan | President and COO | Sell 10b5-1 | 18,750 | $27.98 | $524.5K | 181,641 −9.4% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 12,500 | $27.97 | $349.6K | 129,855 −8.8% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 10,000 | $27.98 | $279.8K | 362,152 −2.7% of holding | |
| Mazumdar Claire 2 fills | Chief Executive Officer | Sell 10b5-1 | 10,000 | $28.42 | $284.2K | 362,180 −2.7% of holding | |
| Cohlhepp Ryan | President and COO | Sell 10b5-1 | 536 | $29.00 | $15.5K | 181,641 −0.3% of holding | |
| Cohlhepp Ryan 3 fills | President and COO | Sell 10b5-1 | 28,214 | $28.98 | $817.6K | 187,558 −13.1% of holding | |
| Hyep Ivan 3 fills | Chief Financial Officer | Sell 10b5-1 | 28,000 | $28.85 | $807.7K | 135,098 −17.2% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 9,200 | $20.42 | $187.9K | 145,355 −6% of holding | |
| Mazumdar Claire 2 fills | Chief Executive Officer | Sell 10b5-1 | 15,000 | $20.04 | $300.6K | 365,130 −3.9% of holding | |
| Cohlhepp Ryan 2 fills | President and COO | Sell 10b5-1 | 12,500 | $20.29 | $253.6K | 196,141 −6% of holding | |
| Raben David | Chief Medical Officer | Sell 10b5-1 | 5,500 | $22.88 | $125.8K | 55,286 −9% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 9,200 | $23.00 | $211.6K | 145,355 −6% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 15,000 | $23.61 | $354.1K | 362,152 −4% of holding | |
| Cohlhepp Ryan 2 fills | President and COO | Sell 10b5-1 | 12,500 | $23.01 | $287.6K | 200,641 −5.9% of holding | |
| Raben David | Chief Medical Officer | Sell 10b5-1 | 5,500 | $18.95 | $104.2K | 55,286 −9% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 9,200 | $18.52 | $170.3K | 145,355 −6% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 1,596 | $18.95 | $30.2K | 339,392 −0.5% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 6,905 | $18.78 | $129.7K | 339,392 −2% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 6,499 | $18.84 | $122.4K | 339,392 −1.9% of holding | |
| Cohlhepp Ryan 2 fills | President and COO | Sell 10b5-1 | 12,500 | $19.66 | $245.7K | 205,141 −5.7% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 36,766 | $19.17 | $704.7K | 339,392 −9.8% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 3,817 | $18.75 | $71.6K | 339,392 −1.1% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 1,786 | $18.74 | $33.5K | 339,392 −0.5% of holding | |
| Raben David | Chief Medical Officer | Sell 10b5-1 | 16,300 | $18.52 | $301.9K | 55,286 −22.8% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 2,963 | $18.25 | $54.1K | 145,355 −2% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 2,631 | $18.73 | $49.3K | 339,392 −0.8% of holding | |
| Cohlhepp Ryan 2 fills | President and COO | Sell 10b5-1 | 17,392 | $18.16 | $315.9K | 209,641 −7.7% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 13,555 | $18.22 | $246.9K | 145,355 −8.5% of holding | |
| Raben David | Chief Medical Officer | Sell 10b5-1 | 200 | $18.45 | $3.7K | 55,286 −0.4% of holding | |
| Buy | 300,000 | $16.00 | $4.8M | 4,603,418 | |||
| Cohlhepp Ryan 2 fills | President and COO | Sell 10b5-1 | 3,631 | $18.04 | $65.5K | 210,164 −1.7% of holding | |
| Cohlhepp Ryan | President and COO | Sell 10b5-1 | 3,828 | $18.10 | $69.3K | 210,164 −1.8% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 1,882 | $18.15 | $34.2K | 145,355 −1.3% of holding | |
| Cohlhepp Ryan | President and COO | Sell 10b5-1 | 149 | $18.02 | $2.7K | 213,992 −0.1% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 9,200 | $18.31 | $168.5K | 145,355 −6% of holding | |
| Cohlhepp Ryan 2 fills | President and COO | Sell 10b5-1 | 12,500 | $18.68 | $233.5K | 193,641 −6.1% of holding | |
| Raben David 2 fills | Chief Medical Officer | Sell 10b5-1 | 5,500 | $18.84 | $103.6K | 35,497 −13.4% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 41,163 | $18.86 | $776.4K | 309,892 −11.7% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 17,795 | $18.55 | $330.1K | 145,355 −10.9% of holding | |
| Raben David | Chief Medical Officer | Sell 10b5-1 | 5,500 | $18.45 | $101.5K | 35,497 −13.4% of holding | |
| Cohlhepp Ryan 2 fills | President and COO | Sell 10b5-1 | 12,500 | $18.05 | $225.6K | 198,141 −5.9% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 605 | $18.15 | $11.0K | 145,355 −0.4% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 24,103 | $18.83 | $453.8K | 309,892 −7.2% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 13,289 | $18.84 | $250.4K | 309,892 −4.1% of holding | |
| Cohlhepp Ryan 2 fills | President and COO | Sell 10b5-1 | 12,500 | $18.16 | $226.9K | 202,641 −5.8% of holding | |
| Mazumdar Claire | Chief Executive Officer | Sell 10b5-1 | 11,445 | $18.92 | $216.5K | 309,892 −3.6% of holding | |
| Raben David | Chief Medical Officer | Sell 10b5-1 | 22,000 | $18.45 | $405.9K | 35,497 −38.3% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 6,415 | $18.23 | $116.9K | 145,355 −4.2% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 5,627 | $18.21 | $102.5K | 145,355 −3.7% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 18,244 | $18.22 | $332.4K | 145,355 −11.2% of holding | |
| Cohlhepp Ryan 2 fills | President and COO | Sell 10b5-1 | 10,900 | $18.06 | $196.8K | 205,541 −5% of holding | |
| Cohlhepp Ryan 2 fills | President and COO | Sell 10b5-1 | 39,600 | $18.06 | $715.0K | 221,141 −15.2% of holding | |
| Hyep Ivan | Chief Financial Officer | Sell 10b5-1 | 6,514 | $18.17 | $118.4K | 145,355 −4.3% of holding | |
| Meisner Lara | Chief Legal Officer | Sell 10b5-1 | 33,807 | $14.75 | $498.7K | None left | |
| Meisner Lara | Chief Legal Officer | Sell 10b5-1 | 15,829 | $11.49 | $181.9K | None left |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.